AIMS: Given the importance of IgG Fc receptors in immune regulation, we hypothesized that Fcg receptor type III (FcgRIII, CD16) plays an important role in atherogenesis. We therefore analysed the formation of arterial lesions in LDL receptor-deficient (LDLR(-/-)) and FcgRIII(-/-)xLDLR(-/-) double knockout mice at three different points up to 24 weeks of exposure to a high-fat diet. METHODS AND RESULTS: Analysis of Oil Red-O-stained sections revealed no difference in lesion formation between strains after 6 weeks of a high-fat diet, and a modest decrease after 14 weeks in double knockouts relative to LDLR(-/-) controls. After 24 weeks, lesion formation was decreased in the aortic root (30%) and innominate artery (50%) in FcgRIII double knockouts relative to LDLR(-/-) controls. Analysis of peripheral CD4+ T-cells by intracellular flow cytometry from double knockouts after 24 weeks of a high-fat diet revealed statistically significant increases in the percentages of cells producing interferon-gamma, interleukin (IL)-10, and IL-4 relative to controls, differences that were also observed by analyses of whole aortas for cytokine mRNA levels. As determined by flow cytometry, FcgRIII deficiency resulted in an expansion of CD4+ cells and an increase in the CD4 to CD8 ratio. Analysis of plasma anti-oxidized LDL (OxLDL) antibodies by chemiluminescent assay revealed that IgG1 and IgG2c titers to OxLDL were increased in FcgRIII (-/-)xLDLR(-/-) double knockouts relative to LDLR(-/-) controls, while total IgG levels were similar. CONCLUSION: These results reveal altered immunity in FcgRIII(-/-)xLDLR(-/-) mice and a reduction in lesion formation associated with increased production of IL-10 by an expansion of CD4+ T-cells. The reduction in lesion formation was manifest well after evidence of an immune response to OxLDL, suggesting that FcgRIII contributes to lesion progression in murine atherosclerosis.
AIMS: Given the importance of IgG Fc receptors in immune regulation, we hypothesized that Fcg receptor type III (FcgRIII, CD16) plays an important role in atherogenesis. We therefore analysed the formation of arterial lesions in LDL receptor-deficient (LDLR(-/-)) and FcgRIII(-/-)xLDLR(-/-) double knockout mice at three different points up to 24 weeks of exposure to a high-fat diet. METHODS AND RESULTS: Analysis of Oil Red-O-stained sections revealed no difference in lesion formation between strains after 6 weeks of a high-fat diet, and a modest decrease after 14 weeks in double knockouts relative to LDLR(-/-) controls. After 24 weeks, lesion formation was decreased in the aortic root (30%) and innominate artery (50%) in FcgRIII double knockouts relative to LDLR(-/-) controls. Analysis of peripheral CD4+ T-cells by intracellular flow cytometry from double knockouts after 24 weeks of a high-fat diet revealed statistically significant increases in the percentages of cells producing interferon-gamma, interleukin (IL)-10, and IL-4 relative to controls, differences that were also observed by analyses of whole aortas for cytokine mRNA levels. As determined by flow cytometry, FcgRIII deficiency resulted in an expansion of CD4+ cells and an increase in the CD4 to CD8 ratio. Analysis of plasma anti-oxidized LDL (OxLDL) antibodies by chemiluminescent assay revealed that IgG1 and IgG2c titers to OxLDL were increased in FcgRIII (-/-)xLDLR(-/-) double knockouts relative to LDLR(-/-) controls, while total IgG levels were similar. CONCLUSION: These results reveal altered immunity in FcgRIII(-/-)xLDLR(-/-) mice and a reduction in lesion formation associated with increased production of IL-10 by an expansion of CD4+ T-cells. The reduction in lesion formation was manifest well after evidence of an immune response to OxLDL, suggesting that FcgRIII contributes to lesion progression in murineatherosclerosis.
Authors: Filip K Swirski; Mikael J Pittet; Moritz F Kircher; Elena Aikawa; Farouc A Jaffer; Peter Libby; Ralph Weissleder Journal: Proc Natl Acad Sci U S A Date: 2006-06-26 Impact factor: 11.205
Authors: A Poole; J M Gibbins; M Turner; M J van Vugt; J G van de Winkel; T Saito; V L Tybulewicz; S P Watson Journal: EMBO J Date: 1997-05-01 Impact factor: 11.598
Authors: Michael P W Moos; Nicole John; Rolf Gräbner; Silke Nossmann; Bernd Günther; Rüdiger Vollandt; Colin D Funk; Brigitte Kaiser; Andreas J R Habenicht Journal: Arterioscler Thromb Vasc Biol Date: 2005-09-22 Impact factor: 8.311
Authors: D A Bird; K L Gillotte; S Hörkkö; P Friedman; E A Dennis; J L Witztum; D Steinberg Journal: Proc Natl Acad Sci U S A Date: 1999-05-25 Impact factor: 11.205
Authors: A S Plump; L Masucci-Magoulas; C Bruce; C L Bisgaier; J L Breslow; A R Tall Journal: Arterioscler Thromb Vasc Biol Date: 1999-04 Impact factor: 8.311
Authors: Z Mallat; S Besnard; M Duriez; V Deleuze; F Emmanuel; M F Bureau; F Soubrier; B Esposito; H Duez; C Fievet; B Staels; N Duverger; D Scherman; A Tedgui Journal: Circ Res Date: 1999-10-15 Impact factor: 17.367
Authors: W L Hazenbos; I A Heijnen; D Meyer; F M Hofhuis; C R Renardel de Lavalette; R E Schmidt; P J Capel; J G van de Winkel; J E Gessner; T K van den Berg; J S Verbeek Journal: J Immunol Date: 1998-09-15 Impact factor: 5.422
Authors: Shang-Hung Chang; Michael Johns; Joseph J Boyle; Ellen McConnell; Paul A Kirkham; Colin Bicknell; M Zahoor-ul-Hassan Dogar; Robert J Edwards; Oliver Gale-Grant; Ramzi Khamis; Kurrun V V Ramkhelawon; Dorian O Haskard Journal: Hybridoma (Larchmt) Date: 2012-04
Authors: Yanice V Mendez-Fernandez; Bonnie G Stevenson; Cody J Diehl; Nicole A Braun; Nekeithia S Wade; Roman Covarrubias; Sander van Leuven; Joseph L Witztum; Amy S Major Journal: Atherosclerosis Date: 2010-10-20 Impact factor: 5.162
Authors: Joseph J Boyle; Ivy Christou; M Bilal Iqbal; Aivi T Nguyen; Viola W Y Leung; Paul C Evans; Yu Liu; Michael Johns; Paul Kirkham; Dorian O Haskard Journal: Am J Pathol Date: 2012-05-30 Impact factor: 4.307